- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01800448
Variability Analysis During Weaning and Extubation in Critically Ill Patients (NM3)
Cardiopulmonary Monitoring, Skin Conductance and Variability Analysis During Weaning and Extubation in Critically Ill Patients
For critically ill patients, it is important to know when to liberate them from mechanical ventilation (the removal of breathing or endotracheal tube or extubation) and weaning (the progressive decrease of the amount of support that a patient receives from the mechanical ventilation). It is well recognized that prolonged ventilation and weaning harms patients and introduces significant increased costs to the health care system. The investigators objective is to improve the safety of removal of life support in critically ill patients by harnessing information from two new technologies; NM3 and Nexus device. In particular, the investigators are interested in the patterns of variation of respiratory and cardiac signals from the NM3 device, as well as monitor skin conductance with the Nexus device. The combination of these measures has not yet been investigated to date, and could represent a novel set of measures that can be used to help physicians better manage critically ill patients. The current standard of care dictates that once a patient is considered as a candidate for withdrawal from ventilation, a spontaneous breathing trial (SBTs) is performed, where the degree of ventilator support is decreased, and their response is observed to help predict if they will tolerate extubation.
Health is associated with a high degree of variation of physiologic parameters such as heart rate and respiratory rate, and illness & stress are associated with a loss of variability. The analysis of variability of biological signals measures the degree of fluctuations present over time. Previous studies have demonstrated that changes in variability (generally decreases) are observed in illness states, and the degree of this change correlates with illness severity. Several studies have reported that reduced heart or respiratory rate variability (HRV or RRV) during SBTs is associated with extubation failure. Until recently, variability analysis has traditionally been done only on heart rate (HRV), derived from analyzing beat-to-beat intervals from the ubiquitous electrocardiogram (ECG). The investigators aim to apply variability analysis to the respiratory and cardiac signals which represent a rich novel set of muti-organ variability measures whose utility in managing extubation and ventilator weaning has not been investigated to date.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Ontario
-
Ottawa, Ontario, Kanada, K1H8L6
- The Ottawa Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Respiratory failure
- Cardiac failure
- Consent within 48 hours of admission to the ICU
Exclusion Criteria:
- Allergy to skin adhesives
- On study less than 72 hours
Studieplan
Hur är studien utformad?
Designdetaljer
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Ongoing respiratory monitoring
Tidsram: consent to 5 days after extubation
|
looking at the variability of measures of respiratory function that are normally taken during an ICU stay
|
consent to 5 days after extubation
|
Ongoing cardiac monitoring
Tidsram: consent to 5 days after extubation
|
looking at the variability of measures of cardiac function that are normally taken during an ICU stay
|
consent to 5 days after extubation
|
Ongoing skin conductance monitoring
Tidsram: consent to 5 days after extubation
|
looking at skin conductance during the ICU stay
|
consent to 5 days after extubation
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Gwynne Jones, MD, Ottawa Hospital Research Institute
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2011763-01H
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Kritisk sjukdom
-
University of AthensOkändCritical Illness Polyneuromyopati (CIPNM) | ICU Acquired Weakness (ICUAW)Grekland
-
National Taiwan University HospitalAvslutadNeurokirurgi, Critical Ill
-
Unity Health TorontoOkändUtbildning, Medicin | Critical Care UltrasonographyKanada
-
Unity Health TorontoAvslutad
-
Nanjing PLA General HospitalAvslutadCritical Care Patient; Störning i nedre matsmältningskanalen; | Kolonskador;
-
Heidelberg UniversityOkändSedation av cerebrovaskulärt ventilerade Critical Care-patienterTyskland
-
National Taiwan University Clinical Trial CenterRekryteringKardiologi, Critical Care Medicine, AkutsjukvårdTaiwan